{
    "clinical_study": {
        "@rank": "82103", 
        "acronym": "HITOLT", 
        "arm_group": {
            "arm_group_label": "orthotopic Liver Transplantation", 
            "description": "consecutive inclusion of all recipients"
        }, 
        "brief_summary": {
            "textblock": "In a prospective observational study the incidence of Heparin-induced Thrombocytopenia (HIT)\n      Type 2 after orthotopic liver transplantation, associated factors, and hemostaseological\n      findings in thrombocytes and anti-body patterns is going to be investigated."
        }, 
        "brief_title": "Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients", 
        "completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Heparin-induced Thrombocytopenia", 
            "Liver Transplantation"
        ], 
        "condition_browse": {
            "mesh_term": "Thrombocytopenia"
        }, 
        "detailed_description": {
            "textblock": "The investigators examined the frequency of anti-PF4/heparin antibodies (IgG/M/A; EIA) and\n      their functional activity (HIPA) in 38 whole organ deceased donor liver transplant\n      recipients. Additionally, demographic, clinical, donor- and recipient-specific parameters\n      and laboratory findings (ALAT, ASAT, cholinesterase) were investigated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  all consecutive liver transplant recipients between 01/2010 and 08/2011 who\n\n          -  were transplanted at our center after allocation of a liver graft via Eurotransplant\n\n        Exclusion Criteria:\n\n          -  patient's refusal to participate in prospective observation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "consecutive livertransplant recipients of our transplant center, organ allocation via\n        Eurotransplant Foundation, Leiden, The Netherlands; Laboratory investigations performed at\n        the Abteilung f\u00fcr Transfusionsmedizin am Institut f\u00fcr Immunologie und Transfusionsmedizin\n        der Universit\u00e4tsmedizin Greifswald, Greifswald, Germany"
            }
        }, 
        "enrollment": {
            "#text": "39", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01654848", 
            "org_study_id": "TransplanTUM-1", 
            "secondary_id": "HITafterOLT"
        }, 
        "intervention_browse": {
            "mesh_term": "Heparin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "liver transplantation", 
            "thrombocytes", 
            "heparin-induced thrombocytopenia", 
            "multivariate analysis of associated factors of HIT 2 after OLT", 
            "laboratory investigations of HIT-antibodies"
        ], 
        "lastchanged_date": "July 31, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Munich", 
                    "country": "Germany", 
                    "zip": "D-81675"
                }, 
                "name": "Klinikum rechts der Isar der TU M\u00fcnchen"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients: a Prospective Multivariate Analysis of Prognostic Factors and Haemostaseological Findings", 
        "overall_official": {
            "affiliation": "Klinikum rechts der Isar, Dept. of Surgery", 
            "last_name": "Volker Assfalg, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01654848"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "CHIR-Net", 
        "sponsors": {
            "collaborator": {
                "agency": "University Medicine Greifswald", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "CHIR-Net", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "July 2012"
    }
}